Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Cour Pharmaceuticals Development logo

Cour Pharmaceuticals Development

Recent Finacing

Series B

Recent Raise

$50M

Cour Pharmaceuticals Development (COUR Pharma) is a clinical-stage biotechnology company developing antigen-specific immune tolerance therapies for autoimmune diseases using a proprietary nanoparticle platform.

Founded 2015
Illinois, United States
51-100
Private
courpharma.com
PitchBook

Highlights

Focus Areas

Biotechnology
Pharmaceutical
Therapeutics

Recent Investors

Alpha Wave Ventures logo
Angelini Ventures logo
Roche logo
Lumira Ventures logo
Pfizer logo
Bristol Myers Squibb logo
JDRF logo
Pfizer Ventures logo
JDRF T1D Fund logo
Sanofi logo

Financials

$185M

Total Raised

3

Funding rounds

7

Investors


Team

Upgrade to view the team

See the team members at Cour Pharmaceuticals Development.